VILDAGLIPTIN

Sitagliptin inhibits dipeptidyl peptidase IV (DPP-IV), Vildagliptin is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adult patients.

Indications

Type 2 diabetes mellitus

Dosage

Oral; 50mg to 100mg per day along with metformin or sulfonylurea.

Contra-Indications

Hypersensitivity

Special Precautions

Renal impairement

Side Effects

Hypoglycaemia, delayed gastric emptying, nausea and vomiting, flu-like symptoms, headache and dizziness may occur, stevens-johnson syndrome.

Drug Interactions

Risk of hypoglycemia with other anti-diabetic drug.